Gene · 2913
Papers2,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Schizophrenia: A Narrative Review of Etiopathogenetic, Diagnostic and Treatment Aspects. | J Clin Med | 2022 | 36078967 | PubTator, text mining | PubMed |
| COVID-19 Infection and Risk for Neuropsychiatric Symptoms. | Biol Psychiatry | 2022 | 36075670 | PubTator, text mining | PubMed |
| Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment. | CNS Neurosci Ther | 2022 | 36070228 | PubTator, text mining | PubMed |
| Tissue-wide cell-specific proteogenomic modeling reveals novel candidate risk genes in autism spectrum disorders. | NPJ Syst Biol Appl | 2022 | 36068227 | PubTator, text mining | PubMed |
| Cell-type profiling in salamanders identifies innovations in vertebrate forebrain evolution. | Science | 2022 | 36048957 | PubTator, text mining | PubMed |
| Emerging Role of Neuron-Glia in Neurological Disorders: At a Glance. | Oxid Med Cell Longev | 2022 | 36046684 | PubTator, text mining | PubMed |
| Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases. | Pharmacol Ther | 2022 | 36038019 | PubTator, text mining | PubMed |
| Identification of Lethal Inhibitors and Inhibitor Combinations for Mono-Driver versus Multi-Driver Triple-Negative Breast Cancer Cells. | Cancers (Basel) | 2022 | 36011019 | PubTator, text mining | PubMed |
| Neurotransmitters: Potential Targets in Glioblastoma. | Cancers (Basel) | 2022 | 36010960 | PubTator, text mining | PubMed |
| Working memory deficits in children with schizophrenia and its mechanism, susceptibility genes, and improvement: A literature review. | Front Psychiatry | 2022 | 35990059 | PubTator, text mining | PubMed |
| Advances in translating mGlu2 and mGlu3 receptor selective allosteric modulators as breakthrough treatments for affective disorders and alcohol use disorder. | Pharmacol Biochem Behav | 2022 | 35988792 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| Light-Induced Activation of a Specific Type-5 Metabotropic Glutamate Receptor Antagonist in the Ventrobasal Thalamus Causes Analgesia in a Mouse Model of Breakthrough Cancer Pain. | Int J Mol Sci | 2022 | 35887364 | PubTator, text mining | PubMed |
| Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia. | Diagnostics (Basel) | 2022 | 35885427 | PubTator, text mining | PubMed |
| Differential Expression of Serum Exosomal Hsa-miR-487b-3p in Progressive Vitiligo Before and After Systemic Corticosteroid Treatment. | Clin Cosmet Investig Dermatol | 2022 | 35880009 | PubTator, text mining | PubMed |
| Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status. | Elife | 2022 | 35866628 | PubTator, text mining | PubMed |
| Distinct Cell-specific Roles of NOX2 and MyD88 in Epileptogenesis. | Front Cell Dev Biol | 2022 | 35859905 | PubTator, text mining | PubMed |
| Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review). | Int J Oncol | 2022 | 35856439 | PubTator, text mining | PubMed |
| Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia. | CNS Drugs | 2022 | 35831706 | PubTator, text mining | PubMed |
| Advancements in Genomic and Behavioral Neuroscience Analysis for the Study of Normal and Pathological Brain Function. | Front Mol Neurosci | 2022 | 35813067 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2913/papers?page=13